T ranscriptional coactivators p300 and the cAMP response element binding protein (CREB)-binding protein (CBP) are two highly conserved large nuclear phosphoproteins that contain histone acetyl transferase (HAT) activity. These proteins coactivate a large number of DNA-bound sequence specific transcription factors and remodel chromatin by acetylating nucleosomal histones (reviewed in refs. 1 and 2). p300 and CBP have also been shown to acetylate certain transcription factors, thereby affecting their DNA binding and͞or transcriptional activation activities (3) (4) (5) (6) . Targeted gene disruption studies have shown that p300 is essential for normal cell proliferation and development (7) , and haploinsufficiency of CBP in humans gives rise to severe abnormalities characteristic of Rubinstein-Taybi syndrome (8) . Similar abnormalities are observed in mice lacking one allele of CBP, but not p300, suggesting that these two proteins may have certain nonoverlapping functions (9) . p300 and CBP are mutated in several cancers, suggesting a tumor suppressor function of these proteins (reviewed in refs. 1 and 10).
Growth factor-induced G 1 -S transition in mammalian cells is negatively controlled by retinoblastoma tumor suppressor protein Rb that represses E2F-driven cell cycle-related genes by forming a complex with E2F and several cellular repressor complexes (reviewed in ref. 11) . Earlier adenovirus E1A studies have indirectly suggested that p300 may also negatively regulate G 1 phase of the cell cycle. For example, E1A stimulates DNA synthesis in quiescent baby rat kidney cells (12) (13) (14) (15) , and also restimulates DNA replication in terminally differentiated cardiac myocytes through its p300͞CBP-binding domain (16) . Other studies have shown that p300 is involved in terminal differentiation in several cell types including muscles, neurons and enteroendocrine cells (reviewed in ref. 1) . During terminal differentiation, p300 transactivates p21 in cooperation with Sp1, Sp3, or tissue-specific transcription factors, suggesting that p300 may play a role in keeping cells in G 0 ͞G 1 (1, 17) . To assess the role of p300 in cell-cycle control, we recently used an antisense approach, and showed that quiescent human cells depleted of p300 exit G 1 without serum. This premature G 1 exit was found to be the result of the up-regulation of c-Myc that occurs because of depletion of p300 (18) . This result suggests that p300 negatively regulates c-Myc in quiescent cells, and provides an explanation, at least in part, for the effect of E1A on DNA synthesis in quiescent and terminally differentiated cells. However, some p300 functions may also be necessary for cell-cycle progression. For example, fibroblasts from p300 knockout mice are unable to replicate and appear to undergo a cell-cycle arrest (7). p300 acetylates both growth stimulatory transcription factors such as E2F (6) , and growth inhibitory proteins such as p53 (3) , and increases their DNA-binding activities. p300 is underphosphorylated in quiescent cells and hyperphosphorylated during S and G 2 ͞M phases (19) . Phosphorylation of CBP increases during G 1 ͞S boundary with an associated increase in its HAT activity and entry of cells into S phase (20) . Cyclin E͞cyclin-dependent kinase (cdk2) binds to the C-terminal region of p300 in vivo, and this interaction results in the activation of NF-B function, which is required for the coordinated cell-cycle progression (21) . Therefore, the overall role of p300 in the cell cycle is unclear.
To directly assess the role of p300 in G 1 -S transition, we have constructed several stable Rat-1 cell lines capable of expressing p300 from the tetracycline (tet)-responsive promoter. We demonstrate that when p300 is induced in these cells, the serumstimulated induction of c-Myc and S phase are inhibited. We provide evidence that the repression of c-Myc by p300 contributes significantly to the inhibition of G 1 -S transition. Furthermore, by constructing stable cell lines that conditionally overexpress a HAT-defective p300, we also show that the HAT activity of p300 that has been implicated in a number of p300 related functions is not required for this negative regulation. These findings and our published results (18) establish an important role for p300 in maintaining cells in G 1 phase of the cell cycle by preventing inappropriate expression of c-Myc. Thus, p300 may have a universal role as a checkpoint protein, preventing the untimely onset of DNA synthesis in senescent or differentiated cells.
Materials and Methods
Viral Vectors. Adenovirus (Ad) vectors expressing the tet activator͞repressor (Adtet) (22) , and ␤-gal (Ad␤-gal) from the cytomegalovirus promoter were constructed as described (18) . AdM4 is an Ad vector that contains a promoter-luciferase reporter cassette in which four copies of a c-Myc-binding site (E box element) are cloned upstream of the herpes simplex virus (HSV) tk minimal promoter (23) . In AdM4mut the E box sequences are mutated so that c-Myc binds poorly to these sequences (23) . Adc-Myc is an Ad vector that overexpresses c-Myc (24) .
Construction of Rat Cell lines Overexpressing p300. The Rat-12 cell line, originally derived from Rat-1 cells (25) , are indistinguishable from the Rat-1 cells with respect to their growth properties (unpublished results). Hemagglutinin epitope-tagged p300 cDNA (26) was cloned downstream of the tet-responsive promoter in a plasmid that also contains the hygromycin gene driven by the HSV tk promoter. Rat-12 cells were transfected with this plasmid, and selected for hygromycin resistance by using DMEM containing 150 g of hygromycin per ml and 10% FBS. The drug-resistant colonies developed after 3 weeks were cloned and amplified by using standard procedures. Rat cell lines expressing a mutant p300 (p300mutAT2; ref 27) , in which the HAT activity is abolished were constructed under identical conditions. The mutant p300AT2 contained a 6-aa substitution mutation (H1415A, E1423A, Y1423A, L1428S, Y1430A, and H1434A) in the HAT domain. Sixteen h later, they were stimulated with DMEM containing 10% serum, and Poly(A)-containing RNA was isolated at indicated time points in the figure by using a Poly(A)-RNA isolation kit (Qiagen, Valencia, CA). The RNA was then analyzed on Northern blots by using probes specific for Rat c-Myc (a gift of L. Penn, University of Toronto, Toronto), c-Jun, and c-Fos (gifts of R. Tjian, University of California, Berkeley). The RNA bands in the autoradiograms were quantified by using a densitometer. To determine the induced expression of p300 in rat cell clones, cells were infected with Ad␤-gal or Adtet and maintained in DMEM with hygromycin. Twelve hours after infection, they were labeled with 200 uCi (1 Ci ϭ 37 GBq) of [ 35 S]methionine per ml (3,000 Ci͞mmol; Amersham Pharmacia) for 10 h, lysed in radioimmunoprecipitation assay buffer (28) , and equal quantities of protein were immunoprecipitated by using an anti-p300 mAb (sc-584; Santa Cruz Biotechnology), and analyzed on SDS͞8% PAGE as described (13) . For cell-cycle analysis, cells were serum starved, infected with appropriate Ad vectors, and serum stimulated as described above for RNA analysis. The distribution of cells in G 1 , S, and G 2 ͞M phases were quantified by fluorescence-activated cell sorter (FACS) analysis as described (18, 28) .
Cdk Assays. Serum-stimulated cells were lysed at the time points shown in Fig. 3C , and 100 g of protein from each cell lysate was immunoprecipitated with either an anti-cyclin E or cyclin A antibody (sc-751 and sc-481, respectively; Santa Cruz Biotechnology) and then assayed for kinase activity by using histones as substrates (18, 25) .
Endogenous Myc Transcriptional Activation Activity Assays. Cells were serum starved and infected with either Adtet or Ad␤-gal as above, and 2 h later, were superinfected with AdM4 or AdM4mut. Serum starvation was continued for another 16 h and cells were then stimulated with serum. Cells were lysed at the indicated times, and the luciferase activity in the lysates was determined by taking equal quantities of protein and by using a luciferase assay kit (Promega).
HAT Assays. Proliferating cells from clones 37 and AT21 were infected with Adtet or Ad␤-gal for 16 h and lysed, and p300 was immunoprecipitated exactly as described (29) by using a mixture of anti-p300 mAbs (catalog no. 05-267, Upstate Biotechnology). One mg of protein from each cell lysate were assayed for HAT activity by using histones H3 (3 g) and H4 (5 g; both from Upstate Biotechnology), 0.5 uCi of [ 3 H]acetyl CoA (catalog no. TRK688, Amersham Pharmacia) as described (29) . Mouse IgG was as used a negative control.
Results
Conditional Overexpression of p300 in Stable Rat Cell Lines. p300 expressed from the tet-responsive promoter in stable rat cell lines (created as described in Materials and Methods) was induced by infecting them with Adtet. As a control, we used one of the Rat-12 clones (R12G12) that were selected for only the empty vector (25) . In the initial screening, nearly half of the drugresistant clones (5 of 11) were found to contain the inducible p300 gene. Immunoprecipitation analysis shows that the levels of p300 in cells derived from clones 5, 23, 35, 37, and 48, but not in R12G12 control cells infected with Adtet, increased by Ϸ8-to 10-fold when compared with those infected with control vector Ad␤-gal (Fig. 1A) . Immunoprecipitation of the cell extracts using the HA epitope-specific antibody confirmed that the large increase in p300 levels in clone 37 cells is solely because of the newly introduced p300 gene (Fig. 1 A; data for other clones are not shown). The uninduced levels of p300 in these clones were similar, which were comparable to that of R12G12 cells (Ͻ2-fold difference), indicating that basal level expression of the tetresponsive promoter-driven p300 is minimal (see legend to Fig.  1 for comparison of p300 levels between different lanes). These rat cells expressed normal levels of the endogenous p300 as judged by immunoprecipitation analysis (data not shown). p300 that is overexpressed in these cells coactivated cAMP response element binding protein in a reporter assay, indicating that we did not select cells that overexpress p300 with altered properties (data not shown). Growth rates of clones 5, 35, 37, and 48 were in general comparable to that of R12G12 (Fig. 1B) . Even though p300 levels in clone 23 were comparable to that of other clones, the growth rate of these cells was significantly slower. Reasons for their poor growth rate are not clear at present; it could be due to integration of the exogenous p300 sequences in a locus whose function may be critical for the normal growth of the cell.
Overexpression of p300 in Growth-Arrested Cells Inhibits the G1͞S
Transition. The effects of overexpression of p300 on serumstimulated S-phase induction were studied as described in Materials and Methods (shown schematically in Fig. 2A ). High-level accumulation of p300 in clones 23 and 48 before serum stimulation was confirmed in a parallel time course experiment by inducing p300, followed by immunoprecipitation analysis as shown in Fig. 2B (a 7-to 8-fold increase by Ϸ16 h after Adtet infection in both cases; see Fig. 2 legend for details) . Distribution of cells in G 1 , S, and G 2 ͞M fractions at various time points after serum stimulation were determined by FACS analysis. Each clone was analyzed in three independent experiments that yielded very similar results (except clone 5, which was analyzed only twice), and the representative data are shown in Fig. 2C . Control R12G12 cells emerged from quiescence at an identical rate when infected with either Adtet or Ad␤-gal (Fig. 2C) . Clones 35, 37, and 48 infected with control vector also exited G 1 at rates comparable to that of R12G12. For some unknown reasons, clone 5 cells emerged from G 1 slightly faster than from clone 37 or 48. Consistent with its poor proliferation rate, clone 23 infected with Ad␤-gal exited G 1 significantly more slowly when compared with other clones (Fig. 2C) . Induction of p300 in all p300-overexpressing clones, including clone 23, significantly inhibited the S-phase entry with the levels of inhibition ranging from 50 to 60% at the 18-h time point (for clone 5, 50% inhibition at 16 h after stimulation).
c-Myc, but Not c-Fos or c-Jun, Is Down-Regulated in Cells Overexpressing p300. We showed (18) that when p300 is depleted in quiescent human cells, c-Myc is up-regulated, and such cells exited G 1 without serum. To examine whether p300-overexpressing cells contain reduced Myc expression, p300 was overexpressed in serum-starved cells, was serum stimulated as described for cell-cycle analysis, and then Poly(A)-containing RNA was isolated at 30-min intervals (for c-Fos, 15-min intervals) up to 3 h after serum stimulation, and analyzed on Northern blots by using rat cDNA probes. As shown in Fig. 3A , c-Myc RNA levels were barely detectable at the 0-h time point in clones 37 and 48 infected with Ad␤-gal, appeared at significant levels at 1 h, peaked at Ϸ2 h, and declined thereafter. In cells overexpressing p300, c-Myc RNA levels were reduced by Ϸ4-to 5-fold, which was evident both at the 1-and 2-h time points (compare lanes Ad␤-gal with Adtet in Fig. 3A for c-Myc) . In contrast, c-Fos and c-Jun RNA levels were comparable in control and p300-overexpressing cells. Thus, we conclude that increased p300 levels in serum-starved cells led to reduced steady-state levels of c-Myc RNA, but not of c-Fos or c-Jun RNAs.
To determine whether the reduced c-Myc RNA levels correlate with the endogenous c-Myc transcriptional activation activity, p300 was induced in the cells as shown in Fig. 2 A, infected with an Ad vector containing a promoter-reporter cassette in which four copies of the Myc-binding sites (23) were cloned upstream of a minimal promoter (AdM4; AdM4mut contained mutations in the Myc-binding sites; see Materials and Methods). Sixteen h later, they were stimulated with serum, harvested at 30-min to 1-h intervals, and then assayed for luciferase activity. The promoter-reporter activities in R12G12 cells infected with Ad␤-gal or Adtet rose steadily with comparable increase, and peaked at Ϸ3 h (Fig. 3B and data not shown) . As expected, the levels of the mutant promoter-reporter activities in cells infected with the ␤-gal vector was Ϸ4-to 5-fold lower than that of the WT promoter-reporter. In clone 37 and 48 cells infected with control vector, the WT promoter-reporter activity peaked at Ϸ3 h after serum stimulation (Fig. 3B and data not shown) . In contrast, when p300 was induced in these cells, the reporter activity was significantly reduced. These experiments were repeated twice with reproducible values and data shown are of one such experiment. These results correlate well with the RNA data (Fig.  3A) , and indicate that p300-overexpressing cells synthesize reduced amounts of Myc protein.
Cells Overexpressing p300 Show Decreased Levels of Cdk Activities.
Several S-phase-specific genes, including cyclin E and Cdk2, are direct targets of Myc (30) . To determine whether the repression of Myc and S phase by p300 is associated with a decrease in the levels of Cdk activities, the levels of cyclins E-and A͞Cdk2 activities in clone 37 cells were determined (see Materials and Methods for details). As shown in Fig. 3C , in control cells that transit from G 1 to S normally, induction of cyclin E͞Cdk2 and cyclin A͞Cdk2 activities was detected Ϸ9 h and 12 h after stimulation, respectively (data for time points earlier than 9 h not shown), consistent with the normal coordinated S-phase progression. When p300 was induced in these cells, reduction of cyclin E͞Cdk2 activity was observed as early as 9 h after serum stimulation when compared with that of control cells. Decrease in cyclin A͞Cdk2 activity became evident at the 12-h time point, which is Ϸ3 h later than that observed for cyclin E͞Cdk2 activity. These results are consistent with the reduced Cdk2 activities, contributing to the progression of S phase in p300 overexpressing cells. It is likely that the reduction of Myc protein in p300-overexpressing cells contributed to the reduction of Cdk2 activity, which could be rate limiting for the coordinated S-phase progression.
Overexpression of c-Myc Reverses the p300 Inhibition of S-Phase
Induction. To determine whether overexpression of Myc would reverse p300-repression effects, p300 and Myc were overexpressed in serum-starved clone 48 and 37 cells simultaneously by coinfecting cells with Adtet and an Ad vector overexpressing c-Myc (ref. 24 and Fig. 4A ). We note here that these experiments work well only when cells from early passages are used. The serum-stimulated S-phase entry of cells was then determined by FACS analysis. The average number of cells obtained from three independent experiments with SD at 18 h after serum stimulation (a time point at which cells continue to accumulate in S phase, but do not yet move to G 2 ͞M phase) are shown in Fig. 4 B and C. These data suggest that overexpression of Myc significantly abrogates the inhibition of S-phase induction caused by excess p300 in both cell clones. For example, in clone 48, when only Myc was overexpressed, 62 Ϯ 11% (mean and SD, respectively) of the cells accumulated in S phase ( Fig. 4B; lane 6) . In contrast, only 19 Ϯ 6% of the p300-overexpressing cells accumulated in S phase at this time point (lane 7). However, when Myc and p300 were overexpressed simultaneously, the number of S-phase-specific cells increased to 64 Ϯ 9%, suggesting that overexpression of Myc in this clone completely abrogated the p300-inhibitory effects (lane 8). Overexpression of Myc in clone 37 also showed similar results, although the reversal effect was slightly less efficient. For example, 57 Ϯ 9% and 19 Ϯ 6% of the Myc-, and p300-overexpressing cells, respectively, accumulated at 18 h after serum stimulation (Fig. 4C, lanes 6 and 7) . When Myc and p300 together were overexpressed, the number of cells accumulated in S phase increased to 52 Ϯ 11% (lane 8). The differences between the mean cell numbers in lanes 7 and 8 for both clones are significant, as validated by statistical analysis (see legend to Fig. 4B ). The Myc reversal effects were also evident at the 20-h time point (data not shown). Data presented in Fig. 4 B and C also show that the Myc-overexpressing cells move faster than the control cells, presumably because of the mitogenic effects of Myc.
CyclinA͞Cdk2 and CyclinE͞Cdk2 activities in clone 37 cells shown in Fig. 4C (lanes 5-8) were examined at 15 h after serum stimulation to determine whether overexpression of Myc reverses the inhibition of the Cdk2 activities. Data presented in Fig.  4D clearly show that the cyclin E͞Cdk2 and cyclin A͞Cdk2 activities in cells overexpressing p300 plus Myc increased considerably when compared with cells overexpressing only p300, and they were comparable to that observed in cells expressing only Myc. These data support the FACS data discussed above, and suggest that overexpression of Myc was able to overcome the p300 repression of the S-phase entry.
Inhibition of Induction of c-Myc and S phase by p300 Is Independent
of Its HAT Activity. The HAT activity of both p300 and CBP regulates gene expression by acetylating the transcription factors and the chromatin (1). To determine whether the HAT activity of p300 contributes to the inhibition of G 1 exit and Myc induction, we constructed rat cell lines as described above that conditionally overexpress a mutant p300 that lacks the HAT activity (ref. 27 ; see Materials and Methods). Two such clones were analyzed (AT21, AT41) in which p300 could be induced to levels comparable to that of clone 37 cells that expresses the WT p300 ( Fig. 5A ; Ϸ6-to 7-fold in this experiment), and these cells grew at rates similar to that of clone 37 (Fig. 5B) . Data presented in Fig. 5C suggest that the inhibition of S-phase induction in cells overexpressing mutant p300 are comparable to that observed in cells overexpressing the WT p300 (clone 37; range of inhibition 50-70%). Thus, overexpression of the HAT-defective mutant p300 continues to inhibit the S-phase induction in two independently isolated clones to the same extent as the WT p300. Another clone overexpressing the HAT-defective p300 (AT10) also showed similar S-phase inhibition, although this clone grew more slowly compared with other clones (data not shown). The serum-stimulated Myc activity was also reduced in clone AT21 and AT41 cells to the same extent as that of clone 37 (Ϸ60-65% reduction; Fig. 5D ). To confirm that AT21 and AT41 cells overexpress the HAT-defective p300, p300 in proliferating cells was induced, immunoprecipitated, and assayed for HAT activity in vitro as described in Materials and Methods. Fig. 5E shows a 3.5-fold increase in radiolabeling of histones in p300-induced cells, as compared with uninduced cells for clone 37, but not for clone AT21 cells (induction of p300 in these clones was comparable as determined by immunoprecipitations, data not shown). Thus, we conclude that the HAT activity of p300 does not contribute to the inhibition of the serum-stimulated induction of Myc or S phase.
Discussion
In this article, we showed that the down-regulation of c-Myc by p300 significantly contributes to the inhibition of G 1 -S transition, because overexpression of Myc along with p300 abrogates the p300 inhibitory effects in both clones 37 and 48 cells. These results are consistent with our recently published data (18) , in which we showed that induction of Myc and S phase in cells because of depletion of p300 can be reversed by overexpressing antisense c-Myc in the cells. These results indicate that critical levels of p300 in G 1 phase of the cell cycle negatively regulate c-Myc and maintain cells in G 1 . Our results also provide a molecular basis for the need for viral oncoproteins E1A and SV40 large T to inactivate p300 during cell transformation, and the p300-dependent effect of E1A on DNA synthesis in quiescent (15) , and in terminally differentiated cells (reviewed in ref. 1) . It is conceivable that p300 may contribute to cell differentiation by keeping c-Myc in a repressed state.
The HAT activity of p300 does not contribute to the negative regulation of G 1 or Myc expression, because overexpression of a HAT-defective mutant continues to inhibit Myc and G 1 to the same extent as the WT p300. p300 has been shown to downregulate gene expression by acetylating transcription factors. For example, acetylation of HMG(I)Y by p300 shuts off IFN-␤ gene expression during the postinduction period (4) . Drosophila dCBP acetylates dTCF [homolog of human T cell factor (TCF)], and down-regulates its activity as acetylation interferes in its interaction with armadillo (human homolog of ␤-catenin) that provides the transcription activation function (5); human c-Myc promoter is also activated by TCF4 (31) . Thus, we considered it possible that p300 could acetylate and down-regulate the DNA binding and͞or the transcriptional activation activity of the Myc promoter-specific transcription factors that could contribute to Myc repression. It is unlikely that repression of Myc and S-phase entry by the HAT-defective mutant is due to other p300-associated cellular HAT proteins such as PCAF, which are present at normal levels in these cells, because the induced p300 in AT21 did not show an increase in HAT activity (Fig. 5E) . However, we cannot completely rule out the possibility that other cellular acetylases associating with high levels of p300 may contribute to the effects reported here. Nonetheless, there are several examples in which specific requirement of the HAT activities of p300͞CBP, but not that of PCAF (and vice versa), has been demonstrated (32) (33) (34) (35) . The HAT proteins such as PCAF and p300͞CBP also exhibit differences in substrate specificities with respect to histones (36) .
Our data showing only c-Myc, but not c-Fos or c-Jun transcription, is negatively regulated by p300 in G 0 ͞G 1 (this article and ref. 18) , suggests that the certain Myc promoter-specific transcription factors recruit p300 in G 0 ͞G 1 and repress gene transcription. Studies have shown that in transient assays, c-Myc promoter is repressed by transcription factors including CTCF (37), E2F4 (38) , Mxi (39), MBP-1 (40), MAZ (41), CDP͞cut (42) , and Blimp-1 (43, 44) . E1A also can activate Myc promoter through the PRF element in a p300-dependent manner, suggesting that p300 may cooperate with factors binding to the PRF site and repress Myc promoter (45) . Recent studies (46) suggest that E1A relieves YY1 repression by simultaneously interacting with p300 and YY1, raising the possibility that in serum-starved cells, p300 may cooperate with YY1 in keeping the Myc promoter in a repressed state. The majority of the transcriptional repressors mentioned above have been shown to interact with histone deacetylases (HDACs). p300 interacts with at least some of these transcription factors, although a functional link between p300 and HDAC by means of a transcription factor in repressing gene transcription not been established. One possibility is that in quiescent cells, p300 is recruited to the promoter by these transcriptional repressors that may then form an adapter to bridge the transcription factors and the chromatin remodeling complexes that function as repressors. Several such chromatin remodeling complexes that function as repressors have been described, including hBRM͞BRG-1 (human homologs of yeast SWI͞SNF), HDAC-containing Sin 3 complexes mSin3a and mSin3b, and the histone methylase complex SUV39H1͞HP1 (reviewed in refs. 47 and 48) . Repression of the cyclin E and A, and the c-Fos promoters are mediated by these repressors (49) (50) (51) .
Finally, we are intrigued by our observations that we were unable to develop stable human cell lines conditionally overexpressing p300. For reasons that are not clear at present, Rat-1 cells could tolerate a newly introduced p300 gene, and could readily grow as stable cell lines. At present we do not know whether this difference is related to species difference or because of the embryonic origin of these cells.
